Why Did MedPlus Health's Operational Revenue Drop 3.3% in Q4?
Click to start listening
Synopsis
MedPlus Health Services faces a 3.32% sequential revenue drop in Q4 FY25, but net profit rises significantly. Discover the insights behind these financial results and their implications for the future of this pharmacy retail giant.
Key Takeaways
- Revenue from operations decreased by 3.32% in Q4 FY25.
- Total income fell by 3.08% quarter-on-quarter.
- Net profit increased by 12.01% to Rs 51.3 crore.
- Store count reached 4,712 with the addition of 100 new stores.
- Operating EBITDA rose by 38.2% YoY to Rs 80.33 crore.
Mumbai, May 28 (NationPress) - Retail pharmacy chain MedPlus Health Services has disclosed that its revenue from operations experienced a decline of 3.32% sequentially, falling to Rs 1,509.6 crore in Q4 FY25 from Rs 1,561.4 crore in Q3 of the previous fiscal year.
In a similar trend, total income decreased by 3.08% quarter-on-quarter (QoQ), amounting to Rs 1,525.4 crore during the same period, as per its filing with the stock exchange.
Despite this, the Hyderabad-based medical laboratory firm reported a substantial 12.01% increase in its consolidated net profit, reaching Rs 51.3 crore in Q4 of FY25, compared to Rs 45.8 crore in the preceding quarter.
On a year-on-year (YoY) comparison, MedPlus demonstrated robust performance, with net profit soaring by 53.7% from Rs 33.5 crore in Q4 FY24. Revenue from operations also saw a modest growth of 1.3% over the same quarter last year (Q4 FY24).
Profit before tax (PBT) nearly doubled, increasing by 91.1% YoY to Rs 61.12 crore for the quarter ending March 31.
The company's operating EBITDA exhibited significant improvement, rising by 38.2% YoY to Rs 80.33 crore in Q4, up from Rs 58.13 crore during the same period last year.
Moreover, the operating EBITDA margin enhanced to 5.3%, compared to 3.9% a year earlier.
Throughout the quarter, MedPlus opened 100 new stores, increasing its total store count to 4,712 as of March 31, according to the company's regulatory filing.
For the complete financial year FY25, MedPlus reported a consolidated net profit of Rs 150.32 crore, reflecting a remarkable 129.6% increase compared to FY24.
The annual revenue from operations also climbed by 9.1%, reaching Rs 6,136.05 crore.
In additional news, the company’s board has approved the appointment of Subrahmanyam Sharma Tatapudi as the new Chief Technology Officer (CTO), effective from 27 May 2025. He was previously the Deputy CTO.
MedPlus Health Services operates as a pharmacy retail company in India, with both online and offline presence. It encompasses retail and wholesale operations, import and distribution, private-label manufacturing, and diagnostic services.
Point of View
MedPlus Health Services is navigating a challenging landscape in the retail pharmacy sector. While the sequential drop in operational revenue is concerning, the significant year-on-year growth in net profit indicates resilience and potential for recovery. As the company expands its footprint and enhances its technology leadership, it remains a pivotal player in India's healthcare market.
NationPress
22/07/2025
Frequently Asked Questions
What caused the decline in MedPlus Health's revenue?
The quarterly decline of 3.32% in MedPlus Health's revenue can be attributed to various market conditions and operational challenges.
How did MedPlus's net profit perform in Q4 FY25?
MedPlus reported a 12.01% increase in net profit, reaching Rs 51.3 crore in Q4 FY25.
What is the total number of stores MedPlus has as of March 31?
As of March 31, MedPlus has expanded its total store count to 4,712.
Who has been appointed as the new CTO of MedPlus?
Subrahmanyam Sharma Tatapudi has been appointed as the new Chief Technology Officer of MedPlus, effective from May 27, 2025.
How did MedPlus perform in FY25 overall?
For the entire financial year FY25, MedPlus reported a consolidated net profit of Rs 150.32 crore, representing a 129.6% increase compared to FY24.
